...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: & on this AGM day we start off the day by dropping over 30%

this after two days of NO trades & on larger volume than normal.

Share
New Message
Please login to post a reply